NCT07904234
Impact of Closed PBSC Collection With Reduced Gas-Phase Oxygen Exposure on Graft Quality and Early Engraftment in Allo-HSCT
StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved 30 days later.
See at-risk trials from Institute of Hematology & Blood Diseases Hospital, China
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Notable Start date pushed from Oct 1, 2026 to Nov 1, 2026
- Primary and study completion pushed from Sep 30, 2029 to Oct 30, 2029
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Time to Neutrophil Engraftment
Timeframe: Up to Day 30 post-transplant
Secondary (11)
pO₂ of PBSC Collection Product
ROS Levels in CD34⁺ Cells
CD34⁺ HSPC Viability
CFU Formation Capacity of CD34⁺ HSPCs
Correlation Between Collection Product pO₂ and Time to ANC Engraftment
Show 6 moreShow less
Correlation Between Collection Product pO₂ and Time to PLT Engraftment
Time to Platelet Engraftment
Incidence of Poor Engraftment
Early Donor Chimerism
Incidence of Donor Adverse Events During and After PBSC Collection
Incidence of Recipient Adverse Events After Transplant
Arms and interventions
Low-Oxygen Closed PBSC CollectionExperimental
Standard PBSC CollectionNo intervention
Procedures: Closed PBSC collection with reduced gas-phase oxygen exposure
Sites
1 site in 1 country
- National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College HospitalTianjin, Tianjin Municipality, China